Benjamin S Echols1, Mark E Clark1, Thomas A Swain2, Ling Chen1, Deepayan Kar3, Yuhua Zhang4, Kenneth R Sloan1, Gerald McGwin2, Ramya Singireddy1, Christian Mays1, David Kilpatrick5, Jason N Crosson6, Cynthia Owsley1, Christine A Curcio7. 1. Department of Ophthalmology and Visual Sciences, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. 2. Department of Ophthalmology and Visual Sciences, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama. 3. Vision Science Training Program, University of Alabama at Birmingham, Birmingham, Alabama. 4. Doheny Eye Institute, Department of Ophthalmology, University of California at Los Angeles, Los Angeles, California. 5. Retina Consultants of Alabama, Birmingham, Alabama. 6. Department of Ophthalmology and Visual Sciences, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Retina Consultants of Alabama, Birmingham, Alabama. 7. Department of Ophthalmology and Visual Sciences, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. Electronic address: christinecurcio@uabmc.edu.
Abstract
PURPOSE: Hyperreflective foci (HRF) are OCT biomarkers for the progression of nonneovascular age-related macular degeneration (AMD) attributed to anteriorly migrated retinal pigment epithelial cells. We examined associations between rod- and cone-mediated vision and HRF plus smaller hyperreflective specks (HRS); we identified a histologic candidate for HRS. DESIGN: Cross-sectional study and histologic survey. PARTICIPANTS: Patients with healthy maculae (n = 34), early AMD (n = 26), and intermediate AMD (n = 41). METHODS: AMD severity was determined by color fundus photography. In OCT scans, HRF and HRS were counted manually. Vision tests probed cones (best-corrected visual acuity [VA], contrast sensitivity), mixed cones and rods (low-luminance VA, low-luminance deficit, mesopic light sensitivity), or rods (scotopic light sensitivity, rod-mediated dark adaptation [RMDA]). An online AMD histopathologic resource was reviewed. MAIN OUTCOME MEASURES: Vision in eyes assessed for HRF and HRS; histologic candidate for HRS. RESULTS: In 101 eyes of 101 patients, HRF and HRS were identified in 25 and 95 eyes, respectively, with good reliability. Hyperreflective foci were present but sparse in healthy eyes, infrequent in early AMD eyes, and frequent but highly variable among intermediate AMD eyes (mean±standard deviation [SD] number per eye, 0.1 ± 0.2, 0.2 ± 0.5, and 1.9 ± 3.4 for healthy, early AMD, and intermediate AMD eyes, respectively). Hyperreflective specks outnumbered HRF in all groups (mean±SD, 4.5 ± 3.2, 6.3 ± 5.8, and 19.4 ± 22.4, respectively). Delayed RMDA was associated strongly with more HRF and HRS (P < 0.0001). Hyperreflective foci also were associated with worse low-luminance VA (P = 0.0117). Hyperreflective specks were associated with worse contrast sensitivity (P = 0.0278), low-luminance VA (P = 0.0010), low-luminance deficit (P = 0.0031), and mesopic (P = 0.0018) and scotopic (P < 0.0001) sensitivity. By histologic analysis, cone lipofuscin was found in outer retinal layers of 25% of healthy aged eyes. CONCLUSIONS: Hyperreflective foci and HRS are markers of cellular activity associated with visual dysfunction, especially delayed RMDA, an AMD risk indicator assessing efficiency of retinoid resupply. Hyperreflective specks may represent lipofuscin translocating inwardly within cones. HRF and HRS may serve as structural end points in clinical trials targeting AMD stages earlier than atrophy expansion. These results should be confirmed in a larger sample.
PURPOSE: Hyperreflective foci (HRF) are OCT biomarkers for the progression of nonneovascular age-related macular degeneration (AMD) attributed to anteriorly migrated retinal pigment epithelial cells. We examined associations between rod- and cone-mediated vision and HRF plus smaller hyperreflective specks (HRS); we identified a histologic candidate for HRS. DESIGN: Cross-sectional study and histologic survey. PARTICIPANTS: Patients with healthy maculae (n = 34), early AMD (n = 26), and intermediate AMD (n = 41). METHODS: AMD severity was determined by color fundus photography. In OCT scans, HRF and HRS were counted manually. Vision tests probed cones (best-corrected visual acuity [VA], contrast sensitivity), mixed cones and rods (low-luminance VA, low-luminance deficit, mesopic light sensitivity), or rods (scotopic light sensitivity, rod-mediated dark adaptation [RMDA]). An online AMD histopathologic resource was reviewed. MAIN OUTCOME MEASURES: Vision in eyes assessed for HRF and HRS; histologic candidate for HRS. RESULTS: In 101 eyes of 101 patients, HRF and HRS were identified in 25 and 95 eyes, respectively, with good reliability. Hyperreflective foci were present but sparse in healthy eyes, infrequent in early AMD eyes, and frequent but highly variable among intermediate AMD eyes (mean±standard deviation [SD] number per eye, 0.1 ± 0.2, 0.2 ± 0.5, and 1.9 ± 3.4 for healthy, early AMD, and intermediate AMD eyes, respectively). Hyperreflective specks outnumbered HRF in all groups (mean±SD, 4.5 ± 3.2, 6.3 ± 5.8, and 19.4 ± 22.4, respectively). Delayed RMDA was associated strongly with more HRF and HRS (P < 0.0001). Hyperreflective foci also were associated with worse low-luminance VA (P = 0.0117). Hyperreflective specks were associated with worse contrast sensitivity (P = 0.0278), low-luminance VA (P = 0.0010), low-luminance deficit (P = 0.0031), and mesopic (P = 0.0018) and scotopic (P < 0.0001) sensitivity. By histologic analysis, cone lipofuscin was found in outer retinal layers of 25% of healthy aged eyes. CONCLUSIONS: Hyperreflective foci and HRS are markers of cellular activity associated with visual dysfunction, especially delayed RMDA, an AMD risk indicator assessing efficiency of retinoid resupply. Hyperreflective specks may represent lipofuscin translocating inwardly within cones. HRF and HRS may serve as structural end points in clinical trials targeting AMD stages earlier than atrophy expansion. These results should be confirmed in a larger sample.
Authors: Rosa Dolz-Marco; Jay P Glover; Orly Gal-Or; Katie M Litts; Jeffrey D Messinger; Yuhua Zhang; Mariano Cozzi; Marco Pellegrini; K Bailey Freund; Giovanni Staurenghi; Christine A Curcio Journal: Ophthalmology Date: 2018-04-04 Impact factor: 12.079
Authors: Joseph G Christenbury; Francisco A Folgar; Rachelle V O'Connell; Stephanie J Chiu; Sina Farsiu; Cynthia A Toth Journal: Ophthalmology Date: 2013-01-23 Impact factor: 12.079
Authors: Christine A Curcio; Emma C Zanzottera; Thomas Ach; Chandrakumar Balaratnasingam; K Bailey Freund Journal: Invest Ophthalmol Vis Sci Date: 2017-05-01 Impact factor: 4.799
Authors: Andreas Berlin; Mark E Clark; Thomas A Swain; Nathan A Fischer; Gerald McGwin; Kenneth R Sloan; Cynthia Owsley; Christine A Curcio Journal: Transl Vis Sci Technol Date: 2022-10-03 Impact factor: 3.048
Authors: Manuela Völkner; Felix Wagner; Lisa Maria Steinheuer; Madalena Carido; Thomas Kurth; Ali Yazbeck; Jana Schor; Stephanie Wieneke; Lynn J A Ebner; Claudia Del Toro Runzer; David Taborsky; Katja Zoschke; Marlen Vogt; Sebastian Canzler; Andreas Hermann; Shahryar Khattak; Jörg Hackermüller; Mike O Karl Journal: Nat Commun Date: 2022-10-19 Impact factor: 17.694
Authors: Ines Lains; Shrinivas J Pundlik; Archana Nigalye; Raviv Katz; Gang Luo; Ivana K Kim; Demetrios G Vavvas; Joan W Miller; John B Miller; Deeba Husain Journal: Retina Date: 2021-10-01 Impact factor: 3.975
Authors: Aaron Y Lee; Cecilia S Lee; Marian S Blazes; Julia P Owen; Yelena Bagdasarova; Yue Wu; Theodore Spaide; Ryan T Yanagihara; Yuka Kihara; Mark E Clark; MiYoung Kwon; Cynthia Owsley; Christine A Curcio Journal: Transl Vis Sci Technol Date: 2020-12-15 Impact factor: 3.283
Authors: Eleonora M Lad; Vivienne Fang; Michel Tessier; Anna Rautanen; Javier Gayan; Sandra S Stinnett; Ulrich F O Luhmann Journal: Ophthalmol Sci Date: 2022-05-20